- Filed
- Jan 13, 2025 12:00 AM ET
- Period of report
- —
Amendment.
Amends a previously filed report.
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | FY 2024 · Mar 31, 2024 | 183.03M sh |
| Shares Diluted | FY 2024 · Mar 31, 2023 | 182.8M sh |
| Shares Diluted | FY 2024 · Mar 31, 2022 | 182.47M sh |
| Shares Outstanding | FY 2024 · Mar 31, 2024 | 183.33M sh |
| Operating Cash Flow | FY 2024 · Mar 31, 2024 | $59.77M |
| Operating Cash Flow restated | FY 2024 · Mar 31, 2024 | 4.98B |
| Operating Cash Flow restated | FY 2024 · Mar 31, 2023 | 8.34B |
| Operating Cash Flow | FY 2024 · Mar 31, 2022 | 2.24B |
| Cash And Equivalents | FY 2024 · Mar 31, 2024 | $49.24M |
| Cash And Equivalents | FY 2024 · Mar 31, 2024 | 4.11B |
| Cash And Equivalents | FY 2024 · Mar 31, 2023 | 3.65B |
| Cash And Equivalents | FY 2024 · Mar 31, 2022 | 3.78B |
| Stockholders Equity restated | FY 2024 · Mar 31, 2024 | 18.07B |
| Stockholders Equity restated | FY 2024 · Mar 31, 2023 | 15.15B |
| Stockholders Equity | FY 2024 · Mar 31, 2022 | 14.48B |
| Stockholders Equity | FY 2024 · Mar 31, 2021 | 13.17B |
| Current Liabilities restated | FY 2024 · Mar 31, 2024 | $283.41M |
| Current Liabilities restated | FY 2024 · Mar 31, 2024 | 23.63B |
| Current Liabilities | FY 2024 · Mar 31, 2023 | 22.06B |
| Total Liabilities restated | FY 2024 · Mar 31, 2024 | $634.6M |
| Total Liabilities restated | FY 2024 · Mar 31, 2024 | 52.91B |
| Total Liabilities restated | FY 2024 · Mar 31, 2023 | 42.26B |
| Current Assets | FY 2024 · Mar 31, 2024 | $290.32M |
| Current Assets | FY 2024 · Mar 31, 2024 | 24.21B |
| Current Assets | FY 2024 · Mar 31, 2023 | 22.32B |
| Total Assets | FY 2024 · Mar 31, 2024 | $851.37M |
| Total Assets | FY 2024 · Mar 31, 2024 | 70.98B |
| Total Assets | FY 2024 · Mar 31, 2023 | 57.4B |
| Eps Diluted restated | FY 2024 · Mar 31, 2024 | $0.01 |
| Eps Diluted restated | FY 2024 · Mar 31, 2024 | 0.91 |
| Eps Diluted restated | FY 2024 · Mar 31, 2023 | 3.64 |
| Eps Diluted | FY 2024 · Mar 31, 2022 | 6.73 |
| Eps Basic restated | FY 2024 · Mar 31, 2024 | $0.01 |
| Eps Basic restated | FY 2024 · Mar 31, 2024 | 0.92 |
| Eps Basic | FY 2024 · Mar 31, 2023 | 3.69 |
| Eps Basic | FY 2024 · Mar 31, 2022 | 6.89 |
| Sga Expense | FY 2024 · Mar 31, 2024 | $77.96M |
| Sga Expense restated | FY 2024 · Mar 31, 2024 | 6.5B |
| Sga Expense restated | FY 2024 · Mar 31, 2023 | 5.73B |
| Sga Expense | FY 2024 · Mar 31, 2022 | 4.94B |
| Net Income restated | FY 2024 · Mar 31, 2024 | $2.03M |
| Net Income restated | FY 2024 · Mar 31, 2024 | 168.94M |
| Net Income | FY 2024 · Mar 31, 2023 | 674.52M |
| Net Income | FY 2024 · Mar 31, 2022 | 1.26B |
| Operating Income | FY 2024 · Mar 31, 2024 | $26M |
| Operating Income restated | FY 2024 · Mar 31, 2024 | 2.17B |
| Operating Income restated | FY 2024 · Mar 31, 2023 | 2.45B |
| Operating Income | FY 2024 · Mar 31, 2022 | 2.87B |
| Cost Of Revenue | FY 2024 · Mar 31, 2024 | $268.41M |
| Cost Of Revenue | FY 2024 · Mar 31, 2024 | 22.38B |
| Cost Of Revenue | FY 2024 · Mar 31, 2023 | 21.38B |
| Cost Of Revenue | FY 2024 · Mar 31, 2022 | 16.04B |
| Revenue | FY 2024 · Mar 31, 2024 | $427.4M |
| Revenue | FY 2024 · Mar 31, 2024 | 35.63B |
| Revenue | FY 2024 · Mar 31, 2023 | 33.4B |
| Revenue | FY 2024 · Mar 31, 2022 | 27.03B |